Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-09T08:56:37.348Z Has data issue: false hasContentIssue false

ON-FARM TRIALS AS ‘INFECTION POINTS’? A RESPONSE TO WALL ET AL.

Published online by Cambridge University Press:  30 January 2019

J. A. ANDERSSON*
Affiliation:
International Maize and Wheat Improvement Center – CIMMYT, and Knowledge, Technology and Innovation group, Wageningen University and Research, P.O. Box 8130, 6700 EW Wageningen, The Netherlands International Maize and Wheat Improvement Center – CIMMYT– Bangladesh. House 10/B, Road 53, Gulshan-2, Dhaka 1213, Bangladesh Wageningen Centre for Development Innovation, Wageningen University and Research, P.O. Box 88, 6700 AB Wageningen, The Netherlands
T. J. KRUPNIK
Affiliation:
International Maize and Wheat Improvement Center – CIMMYT– Bangladesh. House 10/B, Road 53, Gulshan-2, Dhaka 1213, Bangladesh
N. DE ROO
Affiliation:
Wageningen Centre for Development Innovation, Wageningen University and Research, P.O. Box 88, 6700 AB Wageningen, The Netherlands
*
Corresponding author. Email: j.andersson@cgiar.org
Rights & Permissions [Opens in a new window]

Extract

In their response to our paper on the problems of using on-farm trials in efforts to scale-out new crop production technologies and practices among smallholder farmers, Wall et al. (2019) focus on our descriptions of on-farm trials in just one of the three case studies of Agricultural Research for Development (AR4D) projects that were presented. They argue we did not understand the projects’ philosophy and that the biases in farmer and site selection we discussed, do not exist in the southern Africa case study.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2019